Report Library
All Reports
J.P. Morgan 2021 - Day 3
January 13, 2021
The 39th annual J.P. Morgan Healthcare Conference (JPM) is being held virtually from January 11-14, 2021. A list of events and catalysts that were announced or updated during conference today is included in this report.
Highlights from today’s company presentations are included for:
Large Cap
- Bayer AG
- Daiichi Sankyo Co., Ltd.
- Genmab A/S
- Teva Pharmaceutical Industries Ltd.
- UCB S.A.
Mid Cap
- Alkermes plc
- Arena Pharmaceuticals, Inc.
- ChemoCentryx, Inc.
- Dr. Reddy's Laboratories Ltd.
- Halozyme Therapeutics, Inc.
- MorphoSys AG
- NuVasive, Inc.
- Pacira BioSciences, Inc.
- Vifor Pharma Group
Small Cap
- Akebia Therapeutics, Inc.
- Atara Biotherapeutics, Inc.
- BioCryst Pharmaceuticals, Inc.
- G1 Therapeutics Inc.
- Idera Pharmaceuticals, Inc.
- ImmunoGen, Inc.
- Mersana Therapeutics, Inc.
- Omeros Corporation
- Orchard Therapeutics Limited
- Theravance Biopharma Inc.
- Tricida, Inc.
For the full report, please download the PDF version at the top of this page.
For J.P. Morgan Healthcare Conference coverage from our Insights editors, stay updated here!
For our disclosures, please read the Biomedtracker Research Standards.
Disease Group Covered: |
Allergy
Autoimmune/immunology Cardiovascular Dermatology Endocrine ENT/Dental Gastroenterology (Non Inflammatory Bowel Disease) Hematology Infectious Disease Metabolic Neurology Not Specified Obstetrics/Gynecology Oncology Ophthalmology Orthopedics Psychiatry Renal Respiratory Rheumatology (Non Autoimmune) Urology |